Navigation Links
Diabetes on the rise,,

ile diabetes, happens when the cells in the pancreas which produce insulin are destroyed.

Patients require daily insulin injections, and a carefully controlled diet, for life. The more common variety, type II diabetes, generally happens later in life, and happens because the cells of the body become less responsive to the regulatory effects of insulin.

This, coupled with a tendency to produce less insulin overall, again leads to levels of glucose sugar in the bloodstream becoming too high, eventually causing tissue damage. Some type II diabetics can control the problem with diet restrictions and exercise, but many also need extra insulin in the form of tablets or injections. In the US, one in ten adults is thought to suffer from diabetes.


'"/>




Page: 1 2

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Irregular Periods Linked to Diabetes
5. Cinnamon combats Diabetes
6. Good News For Women With Gestational Diabetes
7. Processed Meat, Diabetes connection Found
8. Pancreatic Cancer may be linked to Diabetes
9. Gestational Diabetes linked to Chromosomal defici
10. A way to slow the progression of Type 1 Diabetes
11. Celiac Disease in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diabetes the rise

(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...city, state and federal agencies claiming that a U...stringent //enough in treating waste from animals ...nd chronic wasting disease before it was sent to t...anel was set up at the request of the federal and ...
... a rare medicinal plant after more than a century....ia spotted the wild flower, Begonia Tessaricarpa, ...n the northeastern state's Upper Subansari distric...nia Tessaricarpa was long believed to be extinct b...
...o check fitness in students. Jack O'Connell , the ...is year's results of the annual assessment of fift...tered to the fifth, seventh and ninth graders and ...Nearly 1.4 million students took the test this yea...
...n the internet is causing eating disorders among s.../ The NHS Quality Improvement Scotland (NHS QIS) ...een increasing the dangers faced by thousands of S...like anorexia nervosa and bulimia. The first ever...
Other Medicine News:Health News:Complaints Against US Federal lab Over-ruled by Panel 2Health News:Medicinal Plant Rediscovered After 115 Years 2Health News:Internet Health Advice Causing More Harm than Good 2
(Date:10/10/2008)...RNewswire/ -- TriReme Medical Inc. (TMI),announced... (Conformite,Europeenne) marking and commercialize...a unique main vessel stent system specially design...resenting the next generation in bifurcation stent... quarter of the 2.2 million,angioplasty procedures...
(Date:10/9/2008)...Institute, Navigenics, Affymetrix and,Microsoft te.... 9 /- A consortium of health care,t...in a first-of-its-kind,research study to assess th... people who choose to receive such screenings to i...n diseases., Sponsored by Scripps Translational S...
(Date:10/8/2008)...rs Research That May Offer New Hope to,Heart Failu...onally, over 3,000 people are,waiting for a heart ...half,of those will receive a transplant. Now, pion...s paving the way for how to treat congestive heart...News Release, go to:, http://www.prnewswire.com/mn...
(Date:10/8/2008)...re/ -- Vical Incorporated (Nasdaq: VICL ),today i...nical data,demonstrating that the company,s Vaxfec...and protein-based infectious disease vaccines and,...harm.D., Ph.D., Vical,s,Senior Vice President of P...ednesday, October 8, at the World Vaccine Congress...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 1PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 2PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 3PTC Therapeutics Announces Publication of Preclinical Data in PNAS 1315 41 in 3 Hit Songs Mentions Substance Abuse Smoking 10956 11 in 3 Hit Songs Mentions Substance Abuse Smoking 10956 2FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs 10954 1FY2009 Budget Increases International Development Funding but Does Little for Domestic Nutrition Programs 10954 2Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 1Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 2Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 3Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 4Successful Clinical Trials and Launch in New Zealand Spurs Phloe to Enter US Market 1313 5
...th Monoclonal Antibody,Targeting Interleukin-9 (IL...r IL-9 Inhibition in Developing Potential Asthma,T...ire-FirstCall/ --,MedImmune, Inc. today announced ...ess within the company,s inflammatory,disease pipe...studies with its monoclonal antibody (MAb) targeti...
...007 - ARIAD,Pharmaceuticals, Inc. (NASDAQ: ARIA) t...ading cancer centers will present Phase 2 and,1b c...novel mTOR,inhibitor, AP23573, at the annual meeti...SCO) in Chicago, Illinois, on Sunday, June,3, 2007...-agent,AP23573 in patients with soft-tissue and bo...
Other Medicine Technology:MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
Freedom leg bags are part of the Freedom Urinary Collection Systems: a versatile line of leg bags, kits, and accessories designed to meet the varied needs of our customers. These leg bags are offered
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict
Medicine Products: